Los Angeles-based clinical decision software company Regard announced it closed a $61 million Series B round led by Oak HC/FT.
Cedars-Sinai Health Ventures and existing investors Calibrate Ventures, Techstars and TenOneTen Ventures participated in the round.
WHAT IT DOES
Regard offers a clinical support tool that utilizes AI to evaluate patient history, generate clinical decisions and...
Clinical diagnostic and workflow software maker MaxQ AI has received FDA 510(k) marketing clearance for Accipio Ix, an artificial intelligence workflow tool designed to help clinicians prioritize adults patients likely presenting with acute intracranial hemorrhage. The company received notification from the FDA of its decision in late October.
Results generated by the algorithm-based software are...
The FDA has granted diagnostics company IDx’s De Novo request to market its AI-based software system for the autonomous detection of diabetic retinopathy in adults who have diabetes, called IDx-DR.
This decision represents the first AI-based diagnostic system authorized by the FDA for commercialization in the US that can provide a screening decision without the need for clinician interpretation,...
Netherlands-based Wolters Kluwer today announced the launch of UpToDate Advanced, a mobile-friendly physician tool that offers interactive guidance through clinical decision-making.
The new offering builds on medical information and images collected within the company’s longstanding clinical reference information product UpToDate, which is used by 1.5 million physicians annually, according to the...
Winston-Salem, North Carolina-based Impathiq, which makes a data informatics platform that allows hospitals and health systems to integrate new apps and programs into their electronic medical records in accordance with interoperability standards, has announced it raised $350,000 in seed funding and has saved hospitals over $3 million in the year since its launch. Correction: A previous version of...
